|
|
||||||||
Department of Nuclear Medicine Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
Correspondence: For reprints contact: M. Donald Blaufox, MD, PhD, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, New York 10461.
ABSTRACT
Rats with one kidney clamped (2K1C), both kidneys clamped (2K2C), unilaterally nephrectomized with remaining kidney clamped (1K1C), and normals, were studied using 99mTc mercaptoacetyltriglycine ([99mTc]MAG-3) and 131I orthoiodohippurate ([131I]OIH). Clearances of [99mTc]MAG-3 and [131I]OIH were performed after constricted rats became hypertensive. Clearances were repeated after i.v. Captopril. Clearances of [99mTc]MAG-3 and [131I]OIH in normals didn't change significantly after Captopril. Clearances of [99mTc]MAG-3 and [131I]OIH decreased insignificantly after Captopril in the 2K2C model. In the 2K1C group, normal kidney clearance increased ([99mTc]MAG-3 p < 0.01 and [131I]OIH p < 0.025) and clamped kidney clearance decreased after inhibition ([99mTc]MAG-3, p < 0.01, [131I]OIH p < 0.02). Clearances increased in the 1K1C group after Captopril ([99mTc]MAG-3 p < 0.0025 and [131I]OIH, p < 0.001). The ratio of [99mTc]MAG-3 to [131I]OIH before Captopril was 0.81 and 0.84 after Captopril. Changes in renal function after Captopril depend on the model of renovascular hypertension and possibly the dose administered. Technetium-99m MAG-3 clearance parallels [131I]orthoiodohippurate in renovascular hypertension.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |